{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:41:31Z","timestamp":1774867291403,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1023\/a:1007608615682","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T10:54:50Z","timestamp":1040554490000},"page":"1357-1364","source":"Crossref","is-referenced-by-count":87,"title":["Isoprostanes, Novel Markers of Oxidative Injury, Help Understanding the Pathogenesis of Neurodegenerative Diseases"],"prefix":"10.1007","volume":"25","author":[{"given":"Anita","family":"Greco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Minghetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"290420_CR1","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.STR.27.6.1124","volume":"27","author":"P. H. Chan","year":"1996","unstructured":"Chan, P. H. 1996. Role of oxidants in ischemic brain damage. Stroke 27:1124-1129.","journal-title":"Stroke"},{"key":"290420_CR2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0306-9877(94)90070-1","volume":"43","author":"G. F. Weber","year":"1994","unstructured":"Weber, G. F. 1994. The pathophysiology of reactive oxygen intermediates in the central nervous system. Medical Hypotheses 43:223-230.","journal-title":"Medical Hypotheses"},{"key":"290420_CR3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0140-6736(94)92347-7","volume":"344","author":"P. Jenner","year":"1994","unstructured":"Jenner, P. 1994. Oxidative damage in neurodegenerative disease. Lancet 344:796-798.","journal-title":"Lancet"},{"key":"290420_CR4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0166-2236(93)90070-3","volume":"16","author":"C. W. Olanow","year":"1993","unstructured":"Olanow, C. W. 1993. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:439-444.","journal-title":"Trends Neurosci."},{"key":"290420_CR5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1020625717298","volume":"18","author":"A. A. Farooqui","year":"1998","unstructured":"Farooqui, A. A. and Horrocks, L. A. 1998. Lipid peroxides in the free radical pathophysiology of brain diseases. Cell. Mol. Neurobiol. 18:599-608.","journal-title":"Cell. Mol. Neurobiol."},{"key":"290420_CR6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0404.1998.tb07285.x","volume":"98","author":"N. Delanty","year":"1998","unstructured":"Delanty, N. and Dichter, M. A. 1998. Oxidative injury in the nervous system. Acta Neurol. Scand. 98:145-153.","journal-title":"Acta Neurol. Scand."},{"key":"290420_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0404.1989.tb01779.x","volume":"126","author":"B. Halliwell","year":"1989","unstructured":"Halliwell, B. 1989. Oxidants and the central nervous system: some fundamental questions. Acta Neurol. Stand. 126:23-33.","journal-title":"Acta Neurol. Stand."},{"key":"290420_CR8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/10715769809065821","volume":"28","author":"K. Moore","year":"1998","unstructured":"Moore, K. and Roberts II, L. J. 1998. Measurement of lipid peroxidation. Free Rad. Res. 28:659-671.","journal-title":"Free Rad. Res."},{"key":"290420_CR9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/abio.1994.1355","volume":"220","author":"H. C. Yeo","year":"1994","unstructured":"Yeo, H. C., Helbock, H. J., Chyu, D. W., and Ames, B. N. 1994. Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry. Anal. Biochem. 220:391-396.","journal-title":"Anal. Biochem."},{"key":"290420_CR10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/10715769309147499","volume":"18","author":"A. Cailleux","year":"1993","unstructured":"Cailleux, A. and Allain, P. 1993: Is pentane a normal constituent of human breath? Free Rad. Res. Commun. 18:323-327.","journal-title":"Free Rad. Res. Commun."},{"key":"290420_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-5793(87)81455-2","volume":"213","author":"B. Halliwell","year":"1987","unstructured":"Halliwell, B. and Gutteridge, M. C. 1987. The measurement of free radical reactions in human. FEBS Lett. 213:9-14.","journal-title":"FEBS Lett."},{"key":"290420_CR12","first-page":"598","volume":"119","author":"B. Halliwell","year":"1992","unstructured":"Halliwell, B., Gutteridge, M. C., and Cross, C. E. 1992. Free radicals, antioxidants, and human diseases: where are we now? J. Lab. Clin. Med. 119:598-618.","journal-title":"J. Lab. Clin. Med."},{"key":"290420_CR13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/17450399909386163","volume":"52","author":"G. Rimbach","year":"1999","unstructured":"Rimbach, G., Hohler, D., Fischer, A., Roy, S., Virgili, F., Pallauf, J., and Packer, L. 1999. Methods to assess free radicals and oxidative stress in biological systems. Arch. Tierernahr. 52:203-222.","journal-title":"Arch. Tierernahr."},{"key":"290420_CR14","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","volume":"87","author":"J. D. Morrow","year":"1990","unstructured":"Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., and Roberts II, L. J. 1990. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalysed mechanism. Proc. Natl. Acad. Sci. USA 87:9383-9387.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"290420_CR15","doi-asserted-by":"crossref","first-page":"24441","DOI":"10.1074\/jbc.274.35.24441","volume":"274","author":"J. A. Lawson","year":"1999","unstructured":"Lawson, J. A., Rokach, J., and Fitzgerald, G. A. 1999. Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo. J. Biol. Chem. 274:24441-24444.","journal-title":"J. Biol. Chem."},{"key":"290420_CR16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/bbrc.1997.7883","volume":"242","author":"J. Nourooz-Zadeh","year":"1998","unstructured":"Nourooz-Zadeh, J., Liu, E. H., Anggard, E. E., and Halliwell, B. 1998. F4-isoprostanes: a novel class of prostanoids formed during peroxidation of docosahexaenoic acid (DHA). Biochem. Biophys. Res. Commun. 242:338-344.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"290420_CR17","doi-asserted-by":"crossref","first-page":"13605","DOI":"10.1074\/jbc.273.22.13605","volume":"273","author":"L. J. Roberts II","year":"1998","unstructured":"Roberts II, L. J., Montine, T. J., Markesbery, W. R., Tapper, A. R., Hardy, P., Chemtob, S., Dettbarn, W. D., and Morrow, J. D. 1998. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273:13605-13612.","journal-title":"J. Biol. Chem."},{"key":"290420_CR18","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.CIR.97.16.1536","volume":"97","author":"Z. Mallat","year":"1998","unstructured":"Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J., and Tedgui, A. 1998. Elevated levels of 8-iso-prostaglandin F2\u03b1in pericardial fluid of patients with heart failure. Circulation. 97: 1536-1539.","journal-title":"Circulation"},{"key":"290420_CR19","first-page":"2069","volume":"92","author":"M. A. Leo","year":"1997","unstructured":"Leo, M. A., Aleynik, S. I., Siegel, J. H., Kasmin, F. E., Aleynik, M. K., and Lieber, C. S. 1997. F2-isoprostane and 4-hydroxynonenal excretion in human bile of patients with biliary tract and pancreatic disorders. Am. J. Gastroenterol. 92:2069-2072.","journal-title":"Am. J. Gastroenterol."},{"key":"290420_CR20","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/ajrccm.158.5.9803102","volume":"158","author":"P. Montuschi","year":"1998","unstructured":"Montuschi, P., Ciabattoni, G., Paredi, P., Pantelidis, P., duBois, R. M., Kharitonov, S. A., and Barnes, P. J. 1998. 8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung Diseases. Am. J. Respir. Crit. Care Med. 158:1524-1527.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"290420_CR21","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.410440322","volume":"44","author":"T. J. Montine","year":"1998","unstructured":"Montine, T. J., Markesbery, W. R., Morrow, J. D., and Roberts II, L. J. 1998. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Ann. Neurol. 44:410-413.","journal-title":"Ann. Neurol."},{"key":"290420_CR22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-3565(25)12087-9","volume":"275","author":"Z. Wang","year":"1995","unstructured":"Wang, Z., Ciabattoni, G., Creminon, C., Lawson, J., Fitzgerald, G. A., Patrono, C., and Maclouf, J. 1995. Immunological characterization of urinary 8-epi-prostaglandin F2\u03b1excretion in man. J. Pharmacol. Exp. Ther. 275:94-100.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"290420_CR23","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1074\/jbc.270.17.9800","volume":"270","author":"D. Pratic\u00f2","year":"1995","unstructured":"Pratic\u00f2 , D., Lawson, J., and FitzGerald, G. A. 1995. Cycooxygenase dependent formation of 8-epi-PGF2\u03b1in human platelets. 1995. J. Biol. Chem. 270:9800-9808.","journal-title":"J. Biol. Chem."},{"key":"290420_CR24","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1476-5381.1996.tb15535.x","volume":"118","author":"P. Patrignani","year":"1996","unstructured":"Patrignani, P., Santini, G., Panara, M. R., Sciulli, G., Greco, A., Rotondo, M. T., di Giamberardino, M., Maclouf, J., Ciabattoni, G., and Patrono, C. 1996. Induction of prostaglandin endoperoxyde synthase-2 in human monocytes associated with cyclooxygenase-dependent F2-isoprostane formation. Br. J. Pharmacol. 118:1285-1293.","journal-title":"Br. J. Pharmacol."},{"key":"290420_CR25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.CIR.94.1.19","volume":"94","author":"M. P. Reilly","year":"1996","unstructured":"Reilly, M. P., Delanty, N., Lawson, J. A., and Fitzgerald, G. A. 1996. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94:19-25.","journal-title":"Circulation"},{"key":"290420_CR26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-1-4899-0200-9_11","volume-title":"Eicosanoids: from Biotechnology to Therapeutic Applications","author":"G. Ciabattoni","year":"1996","unstructured":"Ciabattoni, G., Patrignani, P., Panara, M. R., Greco, A., Cipollone, F., Davi', G., Di Minno, G., Coppola, A., and Patrono, C. 1996. Studies of isoprostane biosynthesis in man. Pages 111-115, in Folco, Samuelsson, Maclouf and Velo (eds.), Eicosanoids: from Biotechnology to Therapeutic Applications, Plenum Press, New York."},{"key":"290420_CR27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/1044-0305(95)00709-1","volume":"7","author":"R. J. Waugh","year":"1996","unstructured":"Waugh, R. J. and Murphy, R. C. 1996. Mass spectrometric analysis of four reigioisomers of formed by free radicals oxidation of arachidonic acid. J. Am. Soc. Mass. Spectrom. 7:490-499.","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"290420_CR28","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1212\/WNL.53.8.1876","volume":"53","author":"A. Greco","year":"1999","unstructured":"Greco, A., Minghetti, L., Sette, G., Fieschi, C., and Levi, G. 1999. Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis. Neurology 53:1876-1879.","journal-title":"Neurology"},{"key":"290420_CR29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/jnen\/59.10.866","volume":"59","author":"L. Minghetti","year":"2000","unstructured":"Minghetti, L., Greco, A., Cardone, F., Puopolo, M., Ladogana, A., Almonti, S., Cunningham, C., Perry, V. H., Pocchiari, M., and Levi, G. 2000. Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopaties. J. Neuropathol. Exp. Neurol. 59:20-25.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"290420_CR30","doi-asserted-by":"crossref","first-page":"434S","DOI":"10.1093\/jn\/128.2.434S","volume":"128","author":"M. P. Reilly","year":"1998","unstructured":"Reilly, M. P., Lawson, J. A., and Fitzgerald, G. A. 1998. Eicosanoids and Isoecosanoids: indices of cellular function and oxidant stress. J. Nutr. 128:434S-438S.","journal-title":"J. Nutr."},{"key":"290420_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7827(97)00001-5","volume":"36","author":"J. D. Morrow","year":"1997","unstructured":"Morrow, J. D. and Roberts, L. J. 1997. The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid Res. 36:1-21.","journal-title":"Prog. Lipid Res."},{"key":"290420_CR32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0005-2760(96)00162-2","volume":"1345","author":"L. J. Roberts II","year":"1997","unstructured":"Roberts II, L. J. and Morrow, J. D. 1997. The generation and actions of isoprostanes. Biochem. Biophys. Acta 1345:121-135.","journal-title":"Biochem. Biophys. Acta"},{"key":"290420_CR33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0090-6980(92)90077-7","volume":"44","author":"J. D. Morrow","year":"1992","unstructured":"Morrow, J. D., Minton, T. A., and Roberts II, L. J. 1992. The F2-isoprostane, 8-epi-prostaglandin F2\u03b1, a potent agonist of the vascular thromboxane\/endoperoxide receptor, is a platelet thromboxane\/ endoperoxide receptor antagonist. Prostaglandins 44:155-163.","journal-title":"Prostaglandins"},{"key":"290420_CR34","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0022-3565(25)22527-7","volume":"270","author":"K. Yin","year":"1994","unstructured":"Yin, K., Halushka, P. V., Yan, Y.-T., and Wong, P. Y.-K. 1994. Antiaggregatory activity of 8-epi-prostaglandin F2\u03b1and other Fseries prostanoids and their binding to thromboxane A2\/prostaglandin H2 receptors in human platelets. J. Pharmacol. Exp. Ther. 270:1192-1196.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"290420_CR35","doi-asserted-by":"crossref","first-page":"14916","DOI":"10.1074\/jbc.271.25.14916","volume":"271","author":"D. Pratic\u00f2","year":"1996","unstructured":"Pratic\u00f2 , D., Smyth, E., Violi, F., and FitzGerald, G. A. 1996. Local amplification of platelet function by 8-epi-prostaglandin F2\u03b1is not mediated by thromboxane receptor isoforms. J. Biol. Chem. 271:14916-14924.","journal-title":"J. Biol. Chem."},{"key":"290420_CR36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0022-3565(24)36950-2","volume":"282","author":"J. L. Elmhurst","year":"1997","unstructured":"Elmhurst, J. L., Betti, P.-A., and Rangachari, P. K. 1997. Intestinal effects of isoprostanes: evidence for the involvement of prostanoid EP and TP receptors. J. Pharmacol. Exp. Ther. 282:1198-1205.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"290420_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1472-8206.2000.tb00387.x","volume":"14","author":"C. Souvignet","year":"2000","unstructured":"Souvignet, C., Cracowski, J. L., Stanke-Labesque, F., and Bessard, G. 2000. Are isoprostanes a clinical marker for antioxidant drug investigation? Fundam. Clin. Pharmacol. 14:1-10.","journal-title":"Fundam. Clin. Pharmacol."},{"key":"290420_CR38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0889-8553(05)70255-7","volume":"25","author":"J. A. Awad","year":"1996","unstructured":"Awad, J. A., Roberts II, L. J., Burk, R. F., and Morrow, J. D. 1996. Isoprostanes: prostaglandin-like compounds formed in vivo independently of cyclooxygenase: use as clinical indicators of oxidant damage. Gastroenterol. Clin. North Am. 25:409-427.","journal-title":"Gastroenterol. Clin. North Am."},{"key":"290420_CR39","first-page":"257","volume":"120","author":"L. J. Roberts II","year":"1999","unstructured":"Roberts II, L. J., Brame, C. J., Chen, Y., and Morrow, J. D. 1999. Novel eicosanoids. Isoprostanes and related compounds. Methods Mol. Biol. 120:257-285.","journal-title":"Methods Mol. Biol."},{"key":"290420_CR40","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/01.ATV.17.11.2309","volume":"17","author":"C. Patrono","year":"1997","unstructured":"Patrono, C. and Fitzgerald, G. A. 1997. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Atheroscler. Thromb. Vasc. Biol. 17:2309-2315.","journal-title":"Atheroscler. Thromb. Vasc. Biol."},{"key":"290420_CR41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF02253564","volume":"6","author":"T. Liu","year":"1999","unstructured":"Liu, T., Stern, A., Roberts II, L. J., and Morrow, J. D. 1999. The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of AA. Biomed. Sci. 6:226-35.","journal-title":"Biomed. Sci."},{"key":"290420_CR42","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1212\/WNL.52.3.562","volume":"52","author":"T. J. Montine","year":"1999","unstructured":"Montine, T. J., Beal, M. F., Cudkowicz, M. E., O'Donnell, H., Margolin, R. A., McFarland, M. S. N., Bachrach, A. F., Zackert, W. E., Roberts II, L. J., and Morrow, J. D. 1999. Increased CSF F2-isoprostane concentration in probable AD. Neurology 52: 562-565.","journal-title":"Neurology"},{"key":"290420_CR43","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1046\/j.1471-4159.1999.0720734.x","volume":"72","author":"J. Nourooz-Zadeh","year":"1999","unstructured":"Nourooz-Zadeh, J., Liu, E. H., Yhlen, B., Anggard, E. E., and Halliwell, B. 1999. F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. J. Neurochem. 72:734-740.","journal-title":"J. Neurochem."},{"key":"290420_CR44","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1096\/fasebj.12.15.1777","volume":"12","author":"D. Pratic\u00f2","year":"1998","unstructured":"Pratic\u00f2 , D., Lee, V. M. Y., Trojanowski, J. Q., Rokach, J., and Fitzgerald, G. A. 1998. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J. 12:1777-1783.","journal-title":"FASEB J."},{"key":"290420_CR45","first-page":"277","volume":"2","author":"E. Waddington","year":"1999","unstructured":"Waddington, E., Croft, K., Clarnette, R., Mori, T., and Martins, R. 1999. Plasma F2-isoprostane levels are increased in Alzheimer's disease: evidence for increased oxidative stress in vivo. Alzheimer's Report 2:277-282.","journal-title":"Alzheimer's Report"},{"key":"290420_CR46","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.52.5.1104","volume":"23","author":"T. J. Montine","year":"1999","unstructured":"Montine, T. J., Beal, M. F., Cudkowicz, M. E., Biaggioni, I., O'-Donnell, H., Zackert, W. E., Roberts II, L. J., and Morrow, J. D. 1999. Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease. Neurology 23:1104-1105.","journal-title":"Neurology"},{"key":"290420_CR47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1750-3639.1999.tb00215.x","volume":"9","author":"W. R. Markesbery","year":"1999","unstructured":"Markesbery, W. R. and Carney, J. M. 1999. Oxidative alteration in Alzheimer's disease. Brain Pathol. 9:133-146.","journal-title":"Brain Pathol."},{"key":"290420_CR48","first-page":"1","volume":"2","author":"M. P. Mattson","year":"1997","unstructured":"Mattson, M. P. 1997. Central role of oxyradicals in the mechanism of amyloid \u03b2-peptide cytotoxicity. Alzheimer's Disease Review 2:1-14.","journal-title":"Alzheimer's Disease Review"},{"key":"290420_CR49","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/oxfordjournals.aje.a117244","volume":"140","author":"A. Paganini-Hill","year":"1994","unstructured":"Paganini-Hill, A. and Henderson, V. W. 1994. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140: 256-261.","journal-title":"Am. J. Epidemiol."},{"key":"290420_CR50","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1046\/j.1471-4159.1996.66051836.x","volume":"66","author":"Y. Goodman","year":"1996","unstructured":"Goodman, Y., Bruce, A. J., Cheng, B., and Mattson, M. P. 1996. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid b-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1836-1844.","journal-title":"J. Neurochem."},{"key":"290420_CR51","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1471-4159.1999.0730736.x","volume":"73","author":"D. Pratic\u00f2","year":"1999","unstructured":"Pratic\u00f2 , D., Rokach, J., and Tangirala, R. K. 1999. Brains of aged apolipoprotein E-deficient mice have increased levels of F2-isoprostanes, in vivo markers of lipid peroxidation. J. Neurochem. 73:736-41.","journal-title":"J. Neurochem."},{"key":"290420_CR52","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1046\/j.1471-4159.1999.0721146.x","volume":"72","author":"R. J. Mark","year":"1999","unstructured":"Mark, R. J., Fuson, K. S., and May, P. C. 1999. Characterization of 8-epiprostaglandin F2\u03b1as a marker of amyloid \u03b2-peptide-induced oxidative damage. J. Neurochem. 72:1146-1153.","journal-title":"J. Neurochem."},{"key":"290420_CR53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1750-3639.1999.tb00212.x","volume":"9","author":"K. J. Smith","year":"1999","unstructured":"Smith, K. J., Kapoor, R., and Felts, P. A. 1999. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 9:69-92.","journal-title":"Brain Pathol."},{"key":"290420_CR54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0306-9877(92)90121-R","volume":"39","author":"S. M. LeVine","year":"1992","unstructured":"LeVine, S. M. 1992. The role of reactive oxygen species in the pathogenesis of multiple sclerosis. Med. Hypotheses 39:271-274.","journal-title":"Med. Hypotheses"},{"key":"290420_CR55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jnnp.58.2.255","volume":"58","author":"C. Fieschi","year":"1995","unstructured":"Fieschi, C., Gasperini, C., Ristori, G., Bastianello, S., Girmenia, F., Leuzzi, V., Buttinelli, C., and Rasura, M. 1995. Patients with clinically definite multiple sclerosis, white matter abnormalities on MRI, and normal CSF: if not multiple sclerosis, what is it? J. Neurol. Neurosurg. Psychiatry 58:255-256.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"290420_CR56","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"J. F. Kurtzke","year":"1983","unstructured":"Kurtzke, J. F. 1983. Rating neurological impairment in MS. Neurology 33:1444-1452.","journal-title":"Neurology"},{"key":"290420_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(98)00239-2","volume":"95","author":"R. C. van der Veen","year":"1999","unstructured":"van der Veen, R. C. and Roberts II, L. J. 1999. Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids. J. Neuroimmunol. 95:1-7.","journal-title":"J. Neuroimmunol."},{"key":"290420_CR58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","volume":"9","author":"S. E. Browne","year":"1999","unstructured":"Browne, S. E., Ferrante, R. J., and Beal, M. F. 1999. Oxidative stress in Huntington's Disease. Brain Pathol. 9:147-163.","journal-title":"Brain Pathol."},{"key":"290420_CR59","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ana.410430611","volume":"43","author":"R. G. Will","year":"1998","unstructured":"Will, R. G., Alp\u00e9rovitch, A., Poser, S., Pocchiari, M., Hofman, A., Mitrova, E., de Silva, R., D'Alessandro, M., Delasnerie-Laupretre, N., Zerr, I., and van Duijn, C. 1998. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. Ann. Neurol. 43:763-767.","journal-title":"Ann. Neurol."},{"key":"290420_CR60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"P. L. McGeer","year":"1995","unstructured":"McGeer, P. L. and McGeer, E. G. 1995. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:195-218.","journal-title":"Brain Res. Rev."},{"key":"290420_CR61","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0923-2494(99)80046-7","volume":"149","author":"V. H. Perry","year":"1998","unstructured":"Perry, V. H., Bolton, S. J., Antony, D. C., and Betmouni, S. 1998. The contribution of inflammation to acute and chronic neurodegeneration. Res. Immunol. 149:721-725.","journal-title":"Res. Immunol."},{"key":"290420_CR62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/380345a0","volume":"380","author":"D. R. Brown","year":"1996","unstructured":"Brown, D. R., Schmidt, B., and Kretzschmar, H. A. 1996. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380:345-347.","journal-title":"Nature"},{"key":"290420_CR63","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1750-3639.1998.tb00167.x","volume":"8","author":"A. Giese","year":"1998","unstructured":"Giese, A., Brown, D. R., Groschup, M. H., Feldmann, C., Haist, I., and Kretzschmar, H. A. 1998. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8:449-457","journal-title":"Brain Pathol."}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007608615682.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007608615682\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007608615682.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T05:08:08Z","timestamp":1751864888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007608615682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":63,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["290420"],"URL":"https:\/\/doi.org\/10.1023\/a:1007608615682","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}